Skip to main content
OpenTrials

Clinical trial condition

Lymphangioleiomyomatosis

Explore clinical trials studying Lymphangioleiomyomatosis. Study availability and eligibility vary by location and protocol.

41 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Lymphangioleiomyomatosis trial results

Active, not recruiting

Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial

NCT03150914

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations
  • Stanford University Palo Alto, California, United States
  • National Jewish Hospital Denver, Colorado, United States
  • Emory University Atlanta, Georgia, United States
  • Loyola University Chicago, Illinois, United States
View Trial Details
Completed

Letrozole for Lymphangioleiomyomatosis

NCT01353209

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Stanford University Medical Center Stanford, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • University of Miami Miami, Florida, United States
  • Emory University School of Medicine Atlanta, Georgia, United States
View Trial Details
Completed

Efficacy and Safety of Sirolimus in LAM

NCT00414648

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • National Jewish Medical and Research Center Denver, Colorado, United States
  • University of Florida, Gainesville Gainesville, Florida, United States
  • National Heart, Lung, and Blood Institute Bethesda, Maryland, United States
View all 13 locations
View Trial Details

Related conditions